Thomas Pirenne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thomas Pirenne has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alfons Schnitzler
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University Düsseldorf, Germany
1 shared publication - Aline Moorkens
Department of Neurosciences, Laboratory for Neuro- and Psychophysiology, KU Leuven, Leuven, Belgium
1 shared publication - Bahne Hendrik Bahners
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
1 shared publication Esther Florin
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
1 shared publication- Esther Florin
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
1 shared publication - Fabrice Hubschmid
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
1 shared publication
Latest Publications
- Open Access
Static and dynamic noise abolish altruistic biases in Parkinson’s disease independent of deep brain stimulation
There are known alterations in decision-making attributed to Parkinson’s disease. Yet little is known about how those alterations affect decisions in social contexts. We aimed to assess social decision-making in healthy human volunteers as well as people with Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus. Twenty healthy controls and twenty-two people with Parkinson’s in both the stimulation ON and OFF conditions took part in a social discounting task that measured the degree of generosity toward others as a function of social-emotional distance. Using a computational approach, we modelled mechanisms of social discounting across three different models that differed in how they mapped choice valuation onto observed decisions. People with Parkinson’s less often made generous choices than controls. Across all analyses, we found converging evidence that this effect was attributable to increased static and dynamic decision noise, i.e. inhibitory and attentional processes, but not changes in prosocial valuation. While stimulation sped up decisions, there was no effect of deep brain stimulation on social decision-making. Present results indicate that people with Parkinson’s are more prone to random processes such as increased impulsivity and attentional lapses during choices in social situations. Such changes attributed to the disease appear to evade clinical care with dopaminergic compensation and deep brain stimulation.
Open AccessStatic and dynamic noise abolish altruistic biases in Parkinson’s disease independent of deep brain stimulation
There are known alterations in decision-making attributed to Parkinson’s disease. Yet little is known about how those alterations affect decisions in social contexts. We aimed to assess social decision-making in healthy human volunteers as well as people with Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus. Twenty healthy controls and twenty-two people with Parkinson’s in both the stimulation ON and OFF conditions took part in a social discounting task that measured the degree of generosity toward others as a function of social-emotional distance. Using a computational approach, we modelled mechanisms of social discounting across three different models that differed in how they mapped choice valuation onto observed decisions. People with Parkinson’s less often made generous choices than controls. Across all analyses, we found converging evidence that this effect was attributable to increased static and dynamic decision noise, i.e. inhibitory and attentional processes, but not changes in prosocial valuation. While stimulation sped up decisions, there was no effect of deep brain stimulation on social decision-making. Present results indicate that people with Parkinson’s are more prone to random processes such as increased impulsivity and attentional lapses during choices in social situations. Such changes attributed to the disease appear to evade clinical care with dopaminergic compensation and deep brain stimulation.
- 10 December 2025
- Published by World Scientific Pub Co Pte Ltd in International Journal of Neural Systems
- Vol. 35 (13) , 2550082
Subthalamic Nucleus Deep Brain Stimulation Modulates Auditory Steady State Responses in Parkinson’s Disease
Deficits in auditory perception have been widely observed in Parkinson’s disease (PD) patients and the literature attributes it, in part, to impaired central auditory processing. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well-established therapeutic option for patients with advanced PD. Analysis of auditory evoked potentials suggested a modulatory effect of DBS on central auditory processing. To better understand the latter, we investigated whether DBS modulates auditory steady state responses (ASSR) in electroencephalography (EEG) recordings of 5 PD patients. ASSRs are neural responses along central auditory pathways phase-locked to an auditory stimulus which can serve to understand the spectral aspects of central auditory processing. In our analyses, we estimate the intensity of ASSRs with a novel method based on canonical correlation analysis (CCA) and compare them in DBS ON and OFF conditions. Our results suggest that DBS effectively reduces ASSR in patients with PD. A comparison to age-matched healthy participants suggests a pathological effect of PD on ASSRs, which is disrupted by DBS. These findings support our hypothesis that DBS suppresses central auditory processing. Further research is required to assess the symptomatic effect of this modulation, as well as which cortical and subcortical generators are most affected. A better understanding of the auditory side-effects of DBS could lead to improved treatment options.
- 10 December 2025
- Published by World Scientific Pub Co Pte Ltd in International Journal of Neural Systems
- Vol. 35 (13) , 2550082
Subthalamic Nucleus Deep Brain Stimulation Modulates Auditory Steady State Responses in Parkinson’s Disease
Deficits in auditory perception have been widely observed in Parkinson’s disease (PD) patients and the literature attributes it, in part, to impaired central auditory processing. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well-established therapeutic option for patients with advanced PD. Analysis of auditory evoked potentials suggested a modulatory effect of DBS on central auditory processing. To better understand the latter, we investigated whether DBS modulates auditory steady state responses (ASSR) in electroencephalography (EEG) recordings of 5 PD patients. ASSRs are neural responses along central auditory pathways phase-locked to an auditory stimulus which can serve to understand the spectral aspects of central auditory processing. In our analyses, we estimate the intensity of ASSRs with a novel method based on canonical correlation analysis (CCA) and compare them in DBS ON and OFF conditions. Our results suggest that DBS effectively reduces ASSR in patients with PD. A comparison to age-matched healthy participants suggests a pathological effect of PD on ASSRs, which is disrupted by DBS. These findings support our hypothesis that DBS suppresses central auditory processing. Further research is required to assess the symptomatic effect of this modulation, as well as which cortical and subcortical generators are most affected. A better understanding of the auditory side-effects of DBS could lead to improved treatment options.
- Open Access
Parameter scaling of multivariate Granger causality
Estimating causal interactions between signals provides unique insights into their dynamics, and causal inference has been widely applied to electrophysiological data to elucidate brain communication. Multivariate autoregressive models (MVAR) form the basis of most causal estimation methods. However, the high dimensionality of whole-brain data renders MVARs difficult to estimate reliably, and reducing the dimensions to a reasonable range affects causal inference. To address these scalability limitations, we develop sparse Multivariate Granger Causality (sMVGC), a novel method premised on the assumption that true causal connections between signals are sparse, thereby constraining the candidate search space and improving scalability. To motivate sMVGC empirically, we simulate electrophysiological data with known causalities and model how the number of samples, signals, and MVAR order affect the performance and computation time of current algorithms. All algorithms scale at least quadratically with these parameters, yet differ in their sensitivity to signal versus sample count, and the sample requirements for accurate inference scale with the number of signals. Guided by these findings, sMVGC improves parameter scalability while preserving estimation accuracy, and we provide practical parameter ranges and model selection guidance for real-world analyses.
Open AccessParameter scaling of multivariate Granger causality
Estimating causal interactions between signals provides unique insights into their dynamics, and causal inference has been widely applied to electrophysiological data to elucidate brain communication. Multivariate autoregressive models (MVAR) form the basis of most causal estimation methods. However, the high dimensionality of whole-brain data renders MVARs difficult to estimate reliably, and reducing the dimensions to a reasonable range affects causal inference. To address these scalability limitations, we develop sparse Multivariate Granger Causality (sMVGC), a novel method premised on the assumption that true causal connections between signals are sparse, thereby constraining the candidate search space and improving scalability. To motivate sMVGC empirically, we simulate electrophysiological data with known causalities and model how the number of samples, signals, and MVAR order affect the performance and computation time of current algorithms. All algorithms scale at least quadratically with these parameters, yet differ in their sensitivity to signal versus sample count, and the sample requirements for accurate inference scale with the number of signals. Guided by these findings, sMVGC improves parameter scalability while preserving estimation accuracy, and we provide practical parameter ranges and model selection guidance for real-world analyses.